Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Jan C. Brase
Based on 14 articles published since 2009
(Why 14 articles?)
||||
Expertise Level
The expertise of Jan C. Brase ranks in the
  • Top 2.5%
  • ... of 265,285 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 14 articles on the topic.
Graphical view (beta)
Aliases Brase, Jan C   ·   Brase, J C
Work Locations
Details
Most likely:    Novartis      
2018
  • Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Department of Medical Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, Arnau de Vilanova University Hospital, Valencia, Spain. · Department of Medical Oncology, Hospital Clínico de Valencia, Valencia, Spain. · Department of Medical Oncology, Instituto Catalán de Oncología, Hospitalet, Spain. · Department of Medical Oncology, Complejo Universitario de Santiago de Compostela, Santiago de Compostela, Spain. · Department of Medical Oncology, Hospital de Son Llàtzer, Palma de Mallorca, Spain. · Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Son Espases, Palma de Mallorca, Spain. · Department of Medical Oncology, Hospital Provincial Centre de Castelló, Castelló de la Plana, Spain. · Novartis Oncology, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Department of Medical Oncology, Baselga Oncological Institute, Madrid, Spain. · Department of Medical Oncology, Baselga Oncological Institute, Barcelona, Spain. · Pubmed 29045543
2017
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Prometheus Laboratories, San Diego, California. · Foundation Medicine, Cambridge, Massachusetts. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Department of Gynecology, University of Ulm, Ulm, Germany. · Novartis Pharmaceuticals, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Pubmed 28381415
Probable:    Miscellaneous institutions in Cologne      
2016
  • Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutente de Madrid, Calle Maiquez 7, Madrid, Spain. · Sividon Diagnostics GmbH, Cologne, Germany. · Department of Medical Oncology, Valencian Institute of Oncology (IVO), Valencia, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, A Coruña University Hospital Complex, A Coruña, Spain. · Solid Tumor Molecular Diagnostics Laboratory, ARUP Laboratories, Utah, USA. · Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain. · Department of Medical Oncology, Salamanca University Hospital-IBSAL, Salamanca, Spain. · Department of Medical Oncology, Donostia University Hospital, Donostia, Spain. · Department of Medical Oncology, Parc Tauli University Hospital, Sabadell, Spain. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Department of Genetics, University of North Carolina, Chapel Hill, NC, USA. · Department of Pathology & Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA. · Spanish Breast Cancer Research Group (GEICAM), Madrid, Spain. · Department of Medical Oncology, Elche University General Hospital, Elche, Spain. · Pubmed 26909792
2015
  • Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin · Carsten Denkert, German Cancer Consortium (DKTK) · Peter Klare, Praxisklinik and Breast Center · Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin · Micheal Untch, Helios Klinikum Berlin-Buch, Berlin · Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg · Gunter von Minckwitz, Women's Hospital, University of Frankfurt · Hans Tesch, Bethanien Hospital, Frankfurt · Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne · Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf · Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel · Christoph Salat, Onkologische Schwerpunktpraxis, Munich · Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz · Sherko Kümmel, Kliniken Essen-Mitte, Essen · Peter Sinn, University of Heidelberg, Heidelberg · Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach · Toralf Reimer, Klinikum Südstadt, Rostock, Germany · Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia · Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium · and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Pubmed 25534375
2012
  • Sividon Diagnostics GmbH, Nattermannallee 1, 50829, Cologne, Germany. · Pubmed 23039280
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 14 total) written by Jan C. Brase about Breast Neoplasms:

  • A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade. 2018
  • HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2. 2017
  • Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study. 2016
  • Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers. 2015
  • Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients. 2015
  • Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer. 2014
  • Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial. 2014
  • The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients. 2013
  • HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer. 2013
  • EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer. 2013
Show List of Full Article Records
Google Searches

Learn more about Jan C. Brase using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Novartis
Miscellaneous institutions in Cologne
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Novartis
2018
  • Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Department of Medical Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, Arnau de Vilanova University Hospital, Valencia, Spain. · Department of Medical Oncology, Hospital Clínico de Valencia, Valencia, Spain. · Department of Medical Oncology, Instituto Catalán de Oncología, Hospitalet, Spain. · Department of Medical Oncology, Complejo Universitario de Santiago de Compostela, Santiago de Compostela, Spain. · Department of Medical Oncology, Hospital de Son Llàtzer, Palma de Mallorca, Spain. · Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Son Espases, Palma de Mallorca, Spain. · Department of Medical Oncology, Hospital Provincial Centre de Castelló, Castelló de la Plana, Spain. · Novartis Oncology, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Department of Medical Oncology, Baselga Oncological Institute, Madrid, Spain. · Department of Medical Oncology, Baselga Oncological Institute, Barcelona, Spain. · Pubmed 29045543
2017
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Prometheus Laboratories, San Diego, California. · Foundation Medicine, Cambridge, Massachusetts. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Department of Gynecology, University of Ulm, Ulm, Germany. · Novartis Pharmaceuticals, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Pubmed 28381415
Miscellaneous institutions in Cologne
2016
  • Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutente de Madrid, Calle Maiquez 7, Madrid, Spain. · Sividon Diagnostics GmbH, Cologne, Germany. · Department of Medical Oncology, Valencian Institute of Oncology (IVO), Valencia, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, A Coruña University Hospital Complex, A Coruña, Spain. · Solid Tumor Molecular Diagnostics Laboratory, ARUP Laboratories, Utah, USA. · Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain. · Department of Medical Oncology, Salamanca University Hospital-IBSAL, Salamanca, Spain. · Department of Medical Oncology, Donostia University Hospital, Donostia, Spain. · Department of Medical Oncology, Parc Tauli University Hospital, Sabadell, Spain. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Department of Genetics, University of North Carolina, Chapel Hill, NC, USA. · Department of Pathology & Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA. · Spanish Breast Cancer Research Group (GEICAM), Madrid, Spain. · Department of Medical Oncology, Elche University General Hospital, Elche, Spain. · Pubmed 26909792
2015
  • Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin · Carsten Denkert, German Cancer Consortium (DKTK) · Peter Klare, Praxisklinik and Breast Center · Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin · Micheal Untch, Helios Klinikum Berlin-Buch, Berlin · Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg · Gunter von Minckwitz, Women's Hospital, University of Frankfurt · Hans Tesch, Bethanien Hospital, Frankfurt · Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne · Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf · Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel · Christoph Salat, Onkologische Schwerpunktpraxis, Munich · Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz · Sherko Kümmel, Kliniken Essen-Mitte, Essen · Peter Sinn, University of Heidelberg, Heidelberg · Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach · Toralf Reimer, Klinikum Südstadt, Rostock, Germany · Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia · Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium · and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Pubmed 25534375
2012
  • Sividon Diagnostics GmbH, Nattermannallee 1, 50829, Cologne, Germany. · Pubmed 23039280
5 Other Locations Show
Yearly article counts 01112233100
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.